| Long-term dynamics of CA1 hippocampal place codes Y Ziv, LD Burns, ED Cocker, EO Hamel, KK Ghosh, LJ Kitch, AE Gamal, ... Nature neuroscience 16 (3), 264-266, 2013 | 1118 | 2013 |
| Neural ensemble dynamics underlying a long-term associative memory BF Grewe, J Gründemann, LJ Kitch, JA Lecoq, JG Parker, JD Marshall, ... Nature 543 (7647), 670-675, 2017 | 324 | 2017 |
| CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label … MH O'Hara, EM O'Reilly, G Varadhachary, RA Wolff, ZA Wainberg, AH Ko, ... The lancet oncology 22 (1), 118-131, 2021 | 199 | 2021 |
| Entorhinal cortical ocean cells encode specific contexts and drive context-specific fear memory T Kitamura, C Sun, J Martin, LJ Kitch, MJ Schnitzer, S Tonegawa Neuron 87 (6), 1317-1331, 2015 | 167 | 2015 |
| Visualizing mammalian brain area interactions by dual-axis two-photon calcium imaging J Lecoq, J Savall, D Vučinić, BF Grewe, H Kim, JZ Li, LJ Kitch, ... Nature neuroscience 17 (12), 1825-1829, 2014 | 151 | 2014 |
| Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial LJ Padrón, DM Maurer, MH O’Hara, EM O’Reilly, RA Wolff, ZA Wainberg, ... Nature medicine 28 (6), 1167-1177, 2022 | 140 | 2022 |
| Distinct speed dependence of entorhinal island and ocean cells, including respective grid cells C Sun, T Kitamura, J Yamamoto, J Martin, M Pignatelli, LJ Kitch, ... Proceedings of the National Academy of Sciences 112 (30), 9466-9471, 2015 | 134 | 2015 |
| Abstract CT004: A Phase Ib study of CD40 agonistic monoclonal antibody APX005M together with gemcitabine (Gem) and nab-paclitaxel (NP) with or without nivolumab (Nivo) in … MH O'Hara, EM O'Reilly, M Rosemarie, G Varadhachary, ZA Wainberg, ... Cancer research 79 (13_Supplement), CT004-CT004, 2019 | 55 | 2019 |
| A Phase Ib study of CD40 agonistic monoclonal antibody APX005M together with gemcitabine (Gem) and nab-paclitaxel (NP) with or without nivolumab (Nivo) in untreated metastatic … MH O’Hara, EM O’Reilly, M Rosemarie, G Varadhachary, ZA Wainberg, ... Cancer Res 79 (Suppl 13), 2019 | 39 | 2019 |
| Olfactory landmarks and path integration converge to form a cognitive spatial map W Fischler-Ruiz, DG Clark, NR Joshi, V Devi-Chou, L Kitch, M Schnitzer, ... Neuron 109 (24), 4036-4049. e5, 2021 | 37 | 2021 |
| Gemcitabine (Gem) and nab-paclitaxel (NP)±nivolumab (nivo)±CD40 agonistic monoclonal antibody APX005M (sotigalimab), in patients (Pts) with untreated metastatic pancreatic … MH O'Hara, EM O'Reilly, RA Wolff, ZA Wainberg, AH Ko, OE Rahma, ... Journal of Clinical Oncology 39 (15_suppl), 4019-4019, 2021 | 25 | 2021 |
| Olfactory landmarks and path integration converge to form a cognitive spatial map WM Fischler, NR Joshi, V Devi-Chou, LJ Kitch, MJ Schnitzer, LF Abbott, ... BioRxiv, 752360, 2019 | 9 | 2019 |
| Machine learning meets mammalian learning: Statistical tools for large-scale calcium imaging and the study of changing neural codes LJ Kitch Stanford University, 2015 | 6 | 2015 |
| An exploratory study of nivolumab (nivo) with or without ipilimumab (ipi) according to the percentage of tumoral CD8 cells in advanced metastatic cancer. AM Tsimberidou, A Drakaki, D Khalil, S Kummar, FS Hodi, DY Oh, ... Journal of Clinical Oncology 39 (15_suppl), 2573-2573, 2021 | 2 | 2021 |
| 1256 Relationships between irAEs and checkpoint inhibitor response in RADIOHEAD: a large prospective pan-tumor cohort of standard-of-care patients with clinical annotation … A Lucas, S Liang, D Da Silva, A Young, Z Quandt, S Boffo, L Salvador, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| 587 AMADEUS trial: tumor agnostic pre-and on-treatment biomarkers of response to nivolumab plus ipilimumab correlate with on-treatment tumoral T cell infiltration F Alayli, K Okrah, A Tsimberidou, A Drakaki, D Khalil, S Khan, S Hodi, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| Baseline level and early on-treatment clearance of circulating mutant KRAS in metastatic pancreatic ductal adenocarcinoma treated with chemotherapy with or … JE Till, A Abdalla, N Bhagwat, TA Black, Z Wang, SS Yee, PF Gherardini, ... Journal of Clinical Oncology 39 (15_suppl), 4122-4122, 2021 | 1 | 2021 |
| RELATIONSHIPS BETWEEN IRAES AND CHECKPOINT INHIBITOR RESPONSE IN RADIOHEAD: A LARGE PROSPECTIVE PAN-TUMOR COHORT OF STANDARD-OFCARE PATIENTS WITH CLINICAL ANNOTATION, MOLECULAR … A Lucas, S Liang, D Da Silva, A Young, Z Quandt, S Boffo, L Salvador, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 10, A1303-A1303, 2022 | | 2022 |
| 656 Exploratory platform trial to evaluate immunotherapy combinations with chemotherapy for the treatment of patients with previously untreated metastatic pancreatic … J Lyman, E O’Reilly, Z Wainberg, G Fisher, R Wolff, A Ko, M O’Hara, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 559 Biomarker correlates of clinical response with FLT3L/nivo backbone treatment in the multi-cohort phase 1 PORTER platform trial in metastatic castration-resistant prostate … K Shotts, T Howes, J Yu, J Densmore, D Da Silva, D Kumar, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
